Harman GS - Search Results

1

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.

Essell JH, Schroeder MT, Harman GS, Halvorson R, Lew V, Callander N, Snyder M, Lewis SK, Allerton JP, Thompson JM. Essell JH, et al. Among authors: harman gs. Ann Intern Med. 1998 Jun 15;128(12 Pt 1):975-81. doi: 10.7326/0003-4819-128-12_part_1-199806150-00002. Ann Intern Med. 1998. PMID: 9625683 Clinical Trial.

2

Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients.

Essell JH, Thompson JM, Harman GS, Halvorson RD, Snyder MJ, Callander NS, Clement DJ. Essell JH, et al. Among authors: harman gs. Bone Marrow Transplant. 1992 Oct;10(4):367-72. Bone Marrow Transplant. 1992. PMID: 1422493 Clinical Trial.

3

Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide.

Essell JH, Thompson JM, Harman GS, Halvorson RD, Snyder MJ, Johnson RA, Rubinsak JR. Essell JH, et al. Among authors: harman gs. Blood. 1992 May 15;79(10):2784-8. Blood. 1992. PMID: 1586725 Free article. Clinical Trial.

4

Recurrent hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in Hodgkin's disease.

Mercier RJ, Thompson JM, Harman GS, Messerschmidt GL. Mercier RJ, et al. Among authors: harman gs. Am J Med. 1988 Jan;84(1):165-8. doi: 10.1016/0002-9343(88)90028-9. Am J Med. 1988. PMID: 3337120

5

Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).

Copelan EA, Biggs JC, Szer J, Thompson JM, Crilley P, Brodsky I, Klein JL, Kapoor N, Harman GS, Avalos BR. Copelan EA, et al. Among authors: harman gs. Semin Oncol. 1993 Aug;20(4 Suppl 4):33-8; quiz 39. Semin Oncol. 1993. PMID: 8342074 Review.

6

Combination chemotherapy for disseminated malignant melanoma.

Abbott KL, Harman GS. Abbott KL, et al. Among authors: harman gs. Anticancer Drugs. 1995 Aug;6(4):489-97. doi: 10.1097/00001813-199508000-00001. Anticancer Drugs. 1995. PMID: 7579552 Review.

7

Phase I clinical trial of carbetimer.

Hanauske AR, Melink TJ, Harman GS, Clark GM, Craig JB, Koeller JM, Boldt DH, Kantor B, Kisner DL, Orczyk G, et al. Hanauske AR, et al. Among authors: harman gs. Cancer Res. 1988 Sep 15;48(18):5353-7. Cancer Res. 1988. PMID: 2842047

8

Fatal cyclophosphamide cardiomyopathy: its clinical course and treatment.

Lee CK, Harman GS, Hohl RJ, Gingrich RD. Lee CK, et al. Among authors: harman gs. Bone Marrow Transplant. 1996 Sep;18(3):573-7. Bone Marrow Transplant. 1996. PMID: 8879620

9

Phase I clinical investigation of amonafide.

Saez R, Craig JB, Kuhn JG, Weiss GR, Koeller J, Phillips J, Havlin K, Harman G, Hardy J, Melink TJ, et al. Saez R, et al. J Clin Oncol. 1989 Sep;7(9):1351-8. doi: 10.1200/JCO.1989.7.9.1351. J Clin Oncol. 1989. PMID: 2549205 Clinical Trial.

10

Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic study.

Havlin KA, Kuhn JG, Koeller J, Boldt DH, Craig JB, Brown TD, Weiss GR, Cagnola J, Phillips J, Harman G, et al. Havlin KA, et al. Anticancer Drugs. 1995 Apr;6(2):229-36. Anticancer Drugs. 1995. PMID: 7795272 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page